Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanomaJoel Ho, Rodabe N. Amaria, Michael A. Davies et al.|Frontiers in Oncology|2022Cited by 55
Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progressionDevarati Mitra, B. Ashleigh Guadagnolo, Morgan A. Farr et al.|Gynecologic Oncology|2022Cited by 14